Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1978 1
1984 1
1985 2
1986 1
1987 1
1990 1
1992 1
2000 1
2004 1
2006 3
2007 2
2008 2
2009 5
2010 10
2011 5
2012 7
2013 2
2014 5
2015 5
2016 4
2017 7
2018 7
2019 7
2020 13
2021 16
2022 14
2023 7
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Role of RNA modifications in cancer.
Barbieri I, Kouzarides T. Barbieri I, et al. Nat Rev Cancer. 2020 Jun;20(6):303-322. doi: 10.1038/s41568-020-0253-2. Epub 2020 Apr 16. Nat Rev Cancer. 2020. PMID: 32300195 Review.
METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation.
Pandolfini L, Barbieri I, Bannister AJ, Hendrick A, Andrews B, Webster N, Murat P, Mach P, Brandi R, Robson SC, Migliori V, Alendar A, d'Onofrio M, Balasubramanian S, Kouzarides T. Pandolfini L, et al. Among authors: barbieri i. Mol Cell. 2019 Jun 20;74(6):1278-1290.e9. doi: 10.1016/j.molcel.2019.03.040. Epub 2019 Apr 25. Mol Cell. 2019. PMID: 31031083 Free PMC article.
EDITORIAL.
de Barbieri I. de Barbieri I. J Ren Care. 2022 Sep;48(3):142. doi: 10.1111/jorc.12436. J Ren Care. 2022. PMID: 35926892 No abstract available.
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.
Barbieri I, Tzelepis K, Pandolfini L, Shi J, Millán-Zambrano G, Robson SC, Aspris D, Migliori V, Bannister AJ, Han N, De Braekeleer E, Ponstingl H, Hendrick A, Vakoc CR, Vassiliou GS, Kouzarides T. Barbieri I, et al. Nature. 2017 Dec 7;552(7683):126-131. doi: 10.1038/nature24678. Epub 2017 Nov 27. Nature. 2017. PMID: 29186125 Free PMC article.
RNA modifications detection by comparative Nanopore direct RNA sequencing.
Leger A, Amaral PP, Pandolfini L, Capitanchik C, Capraro F, Miano V, Migliori V, Toolan-Kerr P, Sideri T, Enright AJ, Tzelepis K, van Werven FJ, Luscombe NM, Barbieri I, Ule J, Fitzgerald T, Birney E, Leonardi T, Kouzarides T. Leger A, et al. Among authors: barbieri i. Nat Commun. 2021 Dec 10;12(1):7198. doi: 10.1038/s41467-021-27393-3. Nat Commun. 2021. PMID: 34893601 Free PMC article.
The non-coding epitranscriptome in cancer.
Miano V, Codino A, Pandolfini L, Barbieri I. Miano V, et al. Among authors: barbieri i. Brief Funct Genomics. 2021 Mar 27;20(2):94-105. doi: 10.1093/bfgp/elab003. Brief Funct Genomics. 2021. PMID: 33564819 Free PMC article. Review.
Editorial: Roles of non-coding RNAs in tumor growth and development.
Sharma G, Barbieri I, Blandino G, Poli V, Siddiqui JA. Sharma G, et al. Among authors: barbieri i. Front Oncol. 2022 Dec 1;12:1098315. doi: 10.3389/fonc.2022.1098315. eCollection 2022. Front Oncol. 2022. PMID: 36530997 Free PMC article. No abstract available.
Bromodomains as therapeutic targets in cancer.
Barbieri I, Cannizzaro E, Dawson MA. Barbieri I, et al. Brief Funct Genomics. 2013 May;12(3):219-30. doi: 10.1093/bfgp/elt007. Epub 2013 Mar 28. Brief Funct Genomics. 2013. PMID: 23543289 Review.
124 results